Cyrano Therapeutics partners with Resyca for soft mist nasal spray technology to enhance drug delivery for smell loss treatment.

RegCell, a biotech company developing therapies for autoimmune diseases, raises $45.8M and moves headquarters to the U.S. to accelerate growth.

Avenue Capital Group to sell California energy transition assets from Avenue Golden Fund to Partners Group for $2.2 billion.

Institutional investors are increasing private asset allocations, with a focus on infrastructure and real estate, amid shifting market conditions.

OneD Battery Sciences' SINANODE® technology significantly reduces carbon footprint of EV battery anodes, according to Minviro LCA report.

EQT VIII fund agrees to sell Dellner Couplers, a global leader in train connection systems, to Wabtec Corporation for €890 million.

Digital Realty forms 50-50 JV with Bersama Digital Infrastructure Asia to develop and operate data centers across Indonesia.

Orgvue integrates Lightcast's labor market data into its platform, enhancing workforce planning with external market intelligence.

Women's elite sports revenues nearly doubled to $1.88B in 2024, with $2.35B projected for 2025 as the industry focuses on sustainability.

Lorient Capital, a healthcare-focused private investment firm, adds Stephanie DeGennaro as General Counsel and John Cotcher as VP of Compliance and HR Ops.

EQT AB repurchased 345,000 of its own shares for SEK 106.5 million as part of its SEK 2.5 billion repurchase program.

Muinzer recapitalizes 1,356-bed student housing portfolio near University of Tennessee, partnering with Kayne Anderson Real Estate.

J.S. Held announces CEO transition: Jonathon Held to become Executive Chairman, Lee Spirer to assume CEO role starting Q2 2025.

West Monroe partners with ServiceNow to optimize customer service operations, leveraging industry expertise for faster value realization.

Blue Owl Capital hires former KKR executive Blake Shorthouse to lead its global Family Capital business, expanding its reach in the sector.

Chinese CVC funds show resilience in 2024, backing 55% of new unicorns and 33.3% of IPOs, despite a 41.7% drop in new fund registrations.

Nimblemind.ai secures $2.5M funding to accelerate its AI-powered data infrastructure platform for healthcare providers.

Accropeutics raises $12M in Series B Plus funding led by Shenzhen Capital Group, extending cash runway into second half of 2026.

EQT Active Core Infrastructure fund to acquire Crown Castle's Small Cells Solutions business for $4.25 billion, expanding digital infrastructure portfolio.

Porter secures investment from Eir Partners to expand AI-driven care coordination services for improved patient outcomes and risk adjustment.